Raman scattering for dosimetry using GAFCHROMIC EBT3 radiochromic dosimetry film.

PURPOSE: Raman scattering spectra can be thought of as the "fingerprints" of the investigated material. The purpose of this work was to link the absorbed doses of irradiated radiochromic film at the micrometer level with changes in their Raman spectra. METHODS: Raman spectra of irradiated GAFCHROMIC EBT3 film with doses ranging from 0 to 40 Gy were acquired. The excitation wavelengths used in the experiments (457.9 and 647.1 nm) coincided with electronic transitions of the active layer of the film. The effect of resonance Raman scattering enhanced Raman peaks in the resonance region. Spectra were taken in the range of room temperature to around the temperature of liquid nitrogen (-190°C). RESULTS: The Raman peak intensity redistribution is shown for films with different absorbed doses. The ratio of intensities of the 1445 cm-1 band with respect to the 1330 cm-1 band increases with the increase in absorbed dose. This allows building a dose calibration curve for the film. CONCLUSION: The dose distribution of the irradiated film can be identified based on the intensity ratio of the 1445 and 1330 cm-1 bands by means of Raman mapping. This is a noninvasive and computerized readout method which provides micrometer resolution results for the film surface. This is beneficial in the use of radiochromic films as dosimeters for high-precision radiotherapies.

Expression patterns of cancer-testis antigens in human embryonic stem cells and their cell derivatives indicate lineage tracks.

Pluripotent stem cells can differentiate into various lineages but undergo genetic and epigenetic changes during long-term cultivation and, therefore, require regular monitoring. The expression patterns of cancer-testis antigens (CTAs) MAGE-A2, -A3, -A4, -A6, -A8, -B2, and GAGE were examined in undifferentiated human embryonic stem (hES) cells, their differentiated derivatives, teratocarcinoma (hEC) cells, and cancer cell lines of neuroectodermal and mesodermal origin. Undifferentiated hES cells and embryoid body cells expressed MAGE-A3, -A6, -A4, -A8, and GAGEs while later differentiated derivatives expressed only MAGE-A8 or MAGE-A4. Likewise, mouse pluripotent stem cells also express CTAs of Magea but not Mageb family. Despite similarity of the hES and hEC cell expression patterns, MAGE-A2 and MAGE-B2 were detected only in hEC cells but not in hES cells. Moreover, our analysis has shown that CTAs are aberrantly expressed in cancer cell lines and display low tissue specificity. The identification of CTA expression patterns in pluripotent stem cells and their derivatives may be useful for isolation of abnormally CTA-expressing cells to improve the safety of stem-cell based therapy.